{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:48:45Z","timestamp":1792612125874,"version":"4.5.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.44210","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T11:04:36Z","timestamp":1642676676000},"page":"e2144210","source":"Crossref","is-referenced-by-count":46,"title":["In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence"],"prefix":"10.1001","volume":"5","author":[{"given":"Joseph","family":"Burzynski","sequence":"first","affiliation":[{"name":"Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, Queens, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan M.","family":"Mangan","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Kin","family":"Lam","sequence":"additional","affiliation":[{"name":"Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, Queens, New York"},{"name":"Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Macaraig","sequence":"additional","affiliation":[{"name":"Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, Queens, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco M.","family":"Salerno","sequence":"additional","affiliation":[{"name":"Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, Queens, New York"},{"name":"Division of Pulmonary, Allergy & Critical Care, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Rey","family":"deCastro","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neela D.","family":"Goswami","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol Y.","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil W.","family":"Schluger","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy & Critical Care, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Vernon","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"eDOT Study Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Bamrah-Morris","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheridan","family":"Bowers","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Carberry","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chuck","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dias","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Gao","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Garfein","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernard","family":"Green","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon","family":"Gross","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Henry","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hill","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kiskadden-Bechtel","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Lakshman","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Mitropoulos","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M","family":"Nilsen","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Oxtoby","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Philips","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Reaves","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol","family":"Robinson","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Sathi","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brock","family":"Stewart","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anila","family":"Thomas","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanna","family":"Tolochko","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Trieu","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Winston","sequence":"additional","affiliation":[{"name":"for the eDOT Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"issue":"6","key":"zoi211224r1","first-page":"427","article-title":"Tuberculosis control: how the world has changed since 1990.","volume":"80","author":"Hopewell","year":"2002","journal-title":"Bull World Health Organ"},{"issue":"17","key":"zoi211224r2","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJM199404283301702","article-title":"The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis.","volume":"330","author":"Weis","year":"1994","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi211224r3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1086\/jid.2001.184.issue-4","article-title":"The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru.","volume":"184","author":"Su\u00e1rez","year":"2001","journal-title":"J Infect Dis"},{"issue":"7","key":"zoi211224r4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002595","article-title":"Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies.","volume":"15","author":"Alipanah","year":"2018","journal-title":"PLoS Med"},{"issue":"7","key":"zoi211224r5","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis.","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"zoi211224r6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5588\/ijtld.12.0537","article-title":"Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.","volume":"17","author":"Toczek","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"zoi211224r7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2471\/BLT.00.000000","article-title":"Promoting adherence to treatment for tuberculosis: the importance of direct observation.","volume":"85","author":"Frieden","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"11","key":"zoi211224r8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2458-11-19","article-title":"Does directly observed therapy (DOT) reduce drug resistant tuberculosis?","author":"Moonan","year":"2011","journal-title":"BMC Public Health"},{"issue":"4","key":"zoi211224r9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199507273330406","article-title":"Tuberculosis in New York City\u2014turning the tide.","volume":"333","author":"Frieden","year":"1995","journal-title":"N Engl J Med"},{"issue":"8964","key":"zoi211224r10","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(95)91090-5","article-title":"Directly observed therapy for tuberculosis: history of an idea.","volume":"345","author":"Bayer","year":"1995","journal-title":"Lancet"},{"issue":"12","key":"zoi211224r11","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.279.12.943","article-title":"Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the Public Health Tuberculosis Guidelines Panel.","volume":"279","author":"Chaulk","year":"1998","journal-title":"JAMA"},{"issue":"9","key":"zoi211224r12","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s40273-015-0279-6","article-title":"Costs to health services and the patient of treating tuberculosis: a systematic literature review.","volume":"33","author":"Laurence","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"zoi211224r13","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1183\/09031936.00193413","article-title":"Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review.","volume":"43","author":"Tanimura","year":"2014","journal-title":"Eur Respir J"},{"issue":"1","key":"zoi211224r14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01596-2017","article-title":"The impact of digital health technologies on tuberculosis treatment: a systematic review.","volume":"51","author":"Ngwatu","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"zoi211224r15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1183\/13993003.00424-2016","article-title":"Digital health for the End TB Strategy: developing priority products and making them work.","volume":"48","author":"Falzon","year":"2016","journal-title":"Eur Respir J"},{"issue":"2","key":"zoi211224r17","doi-asserted-by":"crossref","DOI":"10.2196\/15727","article-title":"Use of digital technology to enhance tuberculosis control: scoping review.","volume":"22","author":"Lee","year":"2020","journal-title":"J Med Internet Res"},{"issue":"10177","key":"zoi211224r18","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0140-6736(18)32993-3","article-title":"Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.","volume":"393","author":"Story","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"zoi211224r19","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00493-2020","article-title":"Video-observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova.","volume":"56","author":"Ravenscroft","year":"2020","journal-title":"Eur Respir J"},{"issue":"9","key":"zoi211224r20","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1089\/tmj.2019.0190","article-title":"Telemedicine technologies and tuberculosis management: a randomized controlled trial.","volume":"26","author":"Guo","year":"2020","journal-title":"Telemed J E Health"},{"issue":"12","key":"zoi211224r21","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/trstmh\/trv091","article-title":"A randomized controlled study comparing community based with health facility based direct observation of treatment models on patients\u2019 satisfaction and TB treatment outcome in Nigeria.","volume":"109","author":"Adewole","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"zoi211224r22","first-page":"544","article-title":"Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model.","volume":"11","author":"Cavalcante","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"zoi211224r23","first-page":"1524","article-title":"Community vs. facility-based directly observed treatment for tuberculosis in Tanzania\u2019s Kilimanjaro region.","volume":"13","author":"van den Boogaard","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"zoi211224r24","article-title":"Impact of community-based DOT on tuberculosis treatment outcomes: a systematic review and meta-analysis.","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"15","key":"zoi211224r25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12879-015-0945-5","article-title":"Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness.","author":"Wright","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"4","key":"zoi211224r31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1513\/AnnalsATS.202001-027ED","article-title":"Digital technology for tuberculosis medication adherence: promise and peril.","volume":"17","author":"Haberer","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"zoi211224r32","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41591-018-0224-2","article-title":"A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.","volume":"24","author":"Imperial","year":"2018","journal-title":"Nat Med"},{"key":"zoi211224r28","first-page":"90","volume-title":"Sample Size Calculations in Clinical Research","author":"Chow","year":"2008","edition":"2nd ed"},{"key":"zoi211224r29","volume-title":"Categorical Data Analysis","author":"Agresti","year":"2013","edition":"3rd ed"},{"key":"zoi211224r30","doi-asserted-by":"crossref","DOI":"10.1201\/9780429246593","volume-title":"An Introduction to the Bootstrap","author":"Efron","year":"1994","edition":"1st ed"},{"key":"zoi211224r16","unstructured":"Division of Tuberculosis Elimination. Implementing an Electronic Directly Observed Therapy (eDOT) Program: A Toolkit for Tuberculosis Programs. US Centers for Disease Control and Prevention. Updated April 6, 2017. Accessed December 17, 2020. https:\/\/www.cdc.gov\/tb\/publications\/guidestoolkits\/tbedottoolkit.htm"},{"key":"zoi211224r26","unstructured":"Munsiff? SS, Nilsen? D, Fujiwara? PI. Clinical Policies and Protocols Bureau of Tuberculosis Control, 4th Edition. New York City Department of Health and Mental Hygiene. Published March 2008. Accessed September 1, 2020. https:\/\/www1.nyc.gov\/assets\/doh\/downloads\/pdf\/tb\/tb-protocol.pdf"},{"key":"zoi211224r27","unstructured":"PASS Sample Size Software. Non-Inferiority Tests for the Difference Between Two Proportions\u2014Chapter 210. NCSS Statistical Software. Published 2015. Accessed December 15, 2021. http:\/\/ncss.wpengine.netdna-cdn.com\/wp-content\/themes\/ncss\/pdf\/Procedures\/PASS\/Non-Inferiority_Tests_for_the_Difference_Between_Two_Proportions.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2788246\/burzynski_2022_oi_211224_1642007455.21741.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T11:04:50Z","timestamp":1642676690000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2788246"}},"subtitle":["A Randomized Noninferiority Trial"],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.44210","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]}}}